ATRA Atara Biotherapeutics, Inc. Year-over-year net earnings per share growth for the last 12 months
Atara Biotherapeutics (ATRA) is optimizing its workforce, utilizing reserves to develop T-cell platforms. The quarterly EPS growth trajectory demonstrates neutral momentum, where 54.10 reflects the latest metric value. Revenues are based on the commercialization of Ebvallo, while its status as a scientific leader in immunotherapy provides the brand with high authority among specialized transplantation professionals.
ATRA (Atara Biotherapeutics): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Atara Biotherapeutics|ATRA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio atarabio.com|ATRA - Company Cumulative Indebtedness|Debts to Book Capitalization Atara Biotherapeutics Inc|ATRA - Company Long-Term Debts|Company Short-Term Debt Atara Biotherapeutics|Quick Ratio atarabio.com
- earnings and market multiples details:
ATRA - Net Profit|Future Profit Atara Biotherapeutics|ATRA - Company Value to Net Income|Forward P/E Multiple atarabio.com|ATRA - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Atara Biotherapeutics Inc|ATRA - Operating income before deduction of amortization|Earnings per share for the last twelve months Atara Biotherapeutics|ATRA - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months atarabio.com|ATRA - Net earnings per one share growth for the current year|Earnings growth forecast for next year Atara Biotherapeutics
- company sales and revenue statistics:
Fundamental company valuation:Atara Biotherapeutics, Inc. - ATRA
To identify fundamental benchmarks in Atara Biotherapeutics (ATRA) financial reporting, tracking the dynamics of net income per share is critical. By analyzing the relative quarterly change in EPS, an investor assesses the business's financial stability, where daily data recalculations filter out market noise, confirming the stability of this recognized pioneer in allogeneic T-cell therapy and the medical community's fundamental trust in the brand's platform.
Competitor analysis
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|CLDX - Quarterly EPS earnings growth|AUPH (Aurinia Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|BCRX: Year-over-year earnings per share growth rate for the last twelve months|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Dianthus Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months Pharvaris Corp (PHVS)|ABCL (AbCellera Bio) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TRML (Tourmaline Bio, Inc.)|Quarterly EPS earnings growth precigen.com PGEN|PHAR: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics Inc)|UPB: Quarterly EPS earnings growth|ZBIO (Zenas Corp) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome, Inc.) - Quarterly EPS earnings growth|gossamerbio.com (GOSS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months KalVista Pharmaceuticals, Inc. (KALV)|SEPN - Earnings per share growth in annualized terms for the last twelve months|Pieris Pharmaceuticals Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months SVRA (Savara Pharma)|Rigel Pharmaceuticals - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months ANAB (anaptysbio.com)|ATXS: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months enGene Holdings Inc (ENGN)|Year-over-year earnings per share growth for the last twelve months RAPT Therapeutics|JBIO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACRS|Quarterly EPS earnings growth kyvernatx.com (KYTX)|Year-over-year earnings per share growth for the last twelve months Tiziana Life Sciences Ltd TLSA|CABA (Cabaletta Bio Inc.) - Year-over-year net earnings per share trend for the last twelve months|Ventyx Bio - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Theratechnologies, Inc|AVTX (Avalo Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|eledon.com (ELDN) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months AGEN|CLYM (Climb Bio Inc.) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth ZURA|Year-over-year net earnings per share change for the last twelve months aTyr Pharmaceuticals|Quarterly EPS earnings growth ADAG (Adagene Inc.)|IMA - Year-over-year net earnings per share growth for the last 12 months|STTK - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Equillium, Inc. EQ|CNTB: Quarterly EPS earnings growth|Immunic (IMUX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IFRX|XFOR (x4pharma.com) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adicet Bio (ACET)|CELU (celularity.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth INMB (INmune Bio Corp)|Quarterly EPS earnings growth Barinthus Biotherapeutics Corp BRNS|KZR - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months SABS|AKTX: Quarterly EPS earnings growth|Enlivex Therapeutics Ltd. - Year-over-year earnings per one share growth for the last 12 months|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth GeoVax Corp|Year-over-year earnings per share growth for the last twelve months Edesa Biotech, Inc. (EDSA)|IBIO (ibioinc.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Carisma Therapeutics Inc. CARM|XTLB - Year-over-year net earnings per share growth for the last 12 months|Bolt Bio - Quarterly EPS earnings growth|HCWB - Quarterly EPS earnings growth|APVO (aptevotherapeutics.com) - Year-over-year net earnings per share growth for the last 12 months|aimimmuno.com - Year-over-year earnings per one share growth for the last 12 months|ADTX (Aditxt Inc.) - Quarterly EPS earnings growth|GRI Bio Inc (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months XORTX (XRTX)|Year-over-year net earnings per share growth for the last 12 months Vyome Therapeutics HIND|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI - Quarterly EPS earnings growth|affimed.com (AFMD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ALLK|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months IGM Bio IGMS|Quarterly EPS earnings growth ITOS|Quarterly EPS earnings growth Ocean Biomedical Inc (OCEA)|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months THRD (Third Harmonic Bio Inc)
